Skip to content

RANDOMIZED, CONTROLLED LACTOFERRINE STUDY FOR THE PREVENTION OF DIARRHEA IN CHILDREN

RANDOMIZED, CONTROLLED LACTOFERRINE STUDY FOR THE PREVENTION OF DIARRHEA IN CHILDREN

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REPEC
Registry ID
PER-095-07
Enrollment
602
Registered
2007-12-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1 Type of group
bovine lactoferrin 0.5 g or twice a day, daily for 6 months Group name:Group 2 Type of group
Placebo (maltodextrin 0.5 g), twice a day, daily for 6 months

Sponsors

NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Children of both sexes, 12 to 18 months of age living in the District of Independence in Lima, Peru may be included in the study. • Children previously weaned for at least a week may be included in the study.

Exclusion criteria

Exclusion criteria: • Children with exclusive or partial breastfeeding will be excluded. Breastfeeding will be promoted until 24 months of age. • Children with chronic or persistent diarrhea • Children with severe malnutrition {defined by weight for height <-3 DS, height for age <-3 DS) • Children with serious infections who required hospitalization during the month before the study (eg, meningitis, pneumonia, bacteremia) • Children with HIV (data obtained from parents or medical records) • Children with chronic underlying diseases (eg: cancer, immunosuppression, chronic renal failure, congestive heart failure, liver failure) • Children with a history of allergy to cow´s milk or infant formula, eczema, allergic rhinitis or asthma • Children with a family history of eczema, allergic rhinitis, asthma, or milk intolerance.

Design outcomes

Primary

MeasureTime frame
Outcome name:Number of episodes instead of the total number of days with diarrhea, because if the patient requires a specific intervention such as antibiotics for dysentery, it would be unethical to stop the therapy Measure:Number of episodes of diarrhea during the 6-month period. Timepoints:6 months

Secondary

MeasureTime frame
Outcome name:z scores, because they allow comparing weight and height gains between children of different ages. Measure:Determination of growth by measuring z-scores of weight for height Timepoints:6 months

Countries

Peru

Contacts

Public ContactElsa Chea

UNIVERSIDAD PERUANA CAYETANO HEREDIA

echea@upch.edu.pe9595-4866

Outcome results

None listed

Source: REPEC (via WHO ICTRP)